T. Rowe Price Associates
DHC

T. Rowe Price Associates’s Diversified Healthcare Trust DHC Stock Holding History

T. Rowe Price Associates’s Portfolio DHC Stock Details DHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
279,038
+50,094
+22% +$318K ﹤0.01% 1855
2025
Q4 		$1.11M Buy
228,944
+7,578
+3% +$34.4K ﹤0.01% 2035
2025
Q3 		$977K Buy
221,366
+17,390
+9% +$66.2K ﹤0.01% 2083
2025
Q2 		$731K Buy
203,976
+16,607
+9% +$47.9K ﹤0.01% 2123
2025
Q1 		$450K Buy
187,369
+29,336
+19% +$72.4K ﹤0.01% 2289
2024
Q4 		$364K Buy
158,033
+11,435
+8% +$33.7K ﹤0.01% 2422
2024
Q3 		$615K Hold
146,598
– – ﹤0.01% 2173
2024
Q2 		$448K Buy
146,598
+3,585
+3% +$9.1K ﹤0.01% 2231
2024
Q1 		$352K Sell
143,013
-28,169
-16% -$80.7K ﹤0.01% 2357
2023
Q4 		$641K Sell
171,182
-22,418
-12% -$52.7K ﹤0.01% 2067
2023
Q3 		$376K Sell
193,600
-5,740
-3% -$14.6K ﹤0.01% 2246
2023
Q2 		$449K Sell
199,340
-85,763
-30% -$123K ﹤0.01% 2187
2023
Q1 		$385K Sell
285,103
-111,822
-28% -$116K ﹤0.01% 2224
2022
Q4 		$257K Buy
396,925
+87,230
+28% +$86.1K ﹤0.01% 2436
2022
Q3 		$307K Buy
309,695
+95,116
+44% +$152K ﹤0.01% 2370
2022
Q2 		$391K Buy
214,579
+51,844
+32% +$118K ﹤0.01% 2325
2022
Q1 		$521K Buy
162,735
+27,195
+20% +$83.1K ﹤0.01% 2320
2021
Q4 		$419K Sell
135,540
-9,447
-7% -$30.5K ﹤0.01% 2475
2021
Q3 		$492K Buy
144,987
+433
+0.3% +$1.63K ﹤0.01% 2393
2021
Q2 		$604K Sell
144,554
-17,852
-11% -$73.7K ﹤0.01% 2299
2021
Q1 		$776K Buy
162,406
+41,942
+35% +$193K ﹤0.01% 2171
2020
Q4 		$496K Sell
120,464
-9,538
-7% -$37.6K ﹤0.01% 2241
2020
Q3 		$458K Buy
130,002
+226
+0.2% +$882 ﹤0.01% 2128
2020
Q2 		$574K Buy
129,776
+3,128
+2% +$11.1K ﹤0.01% 1998
2020
Q1 		$460K Buy
126,648
+6,380
+5% +$41.9K ﹤0.01% 2027
2019
Q4 		$1.01M Buy
120,268
+9,393
+8% +$79.2K ﹤0.01% 1877
2019
Q3 		$1.03M Buy
110,875
+29,483
+36% +$254K ﹤0.01% 1814
2019
Q2 		$673K Sell
81,392
-1,767
-2% -$14.7K ﹤0.01% 2001
2019
Q1 		$980K Sell
83,159
-2,569
-3% -$32.9K ﹤0.01% 1847
2018
Q4 		$1M Sell
85,728
-28,352
-25% -$421K ﹤0.01% 1794
2018
Q3 		$2M Buy
114,080
+992
+0.9% +$18.2K ﹤0.01% 1622
2018
Q2 		$2.05M Buy
113,088
+1,783
+2% +$29.5K ﹤0.01% 1588
2018
Q1 		$1.74M Buy
111,305
+1,210
+1% +$20.1K ﹤0.01% 1614
2017
Q4 		$2.11M Buy
110,095
+190
+0.2% +$3.64K ﹤0.01% 1572
2017
Q3 		$2.15M Sell
109,905
-8,823
-7% -$172K ﹤0.01% 1558
2017
Q2 		$2.43M Sell
118,728
-5,296
-4% -$113K ﹤0.01% 1516
2017
Q1 		$2.51M Sell
124,024
-6,354
-5% -$125K ﹤0.01% 1524
2016
Q4 		$2.47M Buy
130,378
+38,490
+42% +$746K ﹤0.01% 1521
2016
Q3 		$2.09M Buy
91,888
+2,740
+3% +$60.6K ﹤0.01% 1531
2016
Q2 		$1.86M Buy
89,148
+29,346
+49% +$547K ﹤0.01% 1540
2016
Q1 		$1.07M Buy
59,802
+4,900
+9% +$76.5K ﹤0.01% 1686
2015
Q4 		$815K Sell
54,902
-3,836
-7% -$57.3K ﹤0.01% 1757
2015
Q3 		$943K Hold
58,738
– – ﹤0.01% 1725
2015
Q2 		$1.02M Hold
58,738
– – ﹤0.01% 1740
2015
Q1 		$1.29M Hold
58,738
– – ﹤0.01% 1666
2014
Q4 		$1.29M Hold
58,738
– – ﹤0.01% 1663
2014
Q3 		$1.22M Hold
58,738
– – ﹤0.01% 1686
2014
Q2 		$1.41M Hold
58,738
– – ﹤0.01% 1646
2014
Q1 		$1.31M Hold
58,738
– – ﹤0.01% 1637
2013
Q4 		$1.29M Sell
58,738
-2,926
-5% -$67.7K ﹤0.01% 1626
2013
Q3 		$1.43M Hold
61,664
– – ﹤0.01% 1606
2013
Q2 		$1.58M Buy
+61,664
New +$1.67M ﹤0.01% 1561

Other funds holding DHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFL
Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
H2CM
H/2 Credit Manager Stamford, Connecticut $500M AUM 24.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

T. Rowe Price Associates's DHC Position: Q1 2026 in Review

T. Rowe Price Associates increased its Diversified Healthcare Trust (DHC) stake by 22% in Q1 2026, buying an estimated $318K and bringing the position to 279,038 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

T. Rowe Price Associates first reported a position in DHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.51M in Q1 2017. 230 funds tracked by Wall St. Rank hold DHC as of Q1 2026.

  • T. Rowe Price Associates held 279,038 shares of Diversified Healthcare Trust worth $1.85M as of Q1 2026.
  • T. Rowe Price Associates bought 50,094 Diversified Healthcare Trust shares in Q1 2026, an estimated $318K.
  • Diversified Healthcare Trust made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1855 holding.
  • T. Rowe Price Associates first reported a position in Diversified Healthcare Trust in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Diversified Healthcare Trust position peaked at $2.51M in Q1 2017.
  • 230 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.